HL7 Immunization User Group Monthly Meeting March 12, 2020 2:00 - - PowerPoint PPT Presentation

▶
hl7 immunization user group
SMART_READER_LITE
LIVE PREVIEW

HL7 Immunization User Group Monthly Meeting March 12, 2020 2:00 - - PowerPoint PPT Presentation

May 17, 2023 247 likes •571 views

HL7 Immunization User Group Monthly Meeting March 12, 2020 2:00 PM ET Agenda Welcome - Which perspective do you primarily identify yourself with? AART User Group Updates SISC FHIR Five on FHIR Error Code Review

slide-1
SLIDE 1

HL7 Immunization User Group

Monthly Meeting March 12, 2020 2:00 PM ET

slide-2
SLIDE 2

Agenda

  • Welcome - Which perspective do you primarily identify yourself with?
  • AART User Group
  • Updates
  • SISC
  • FHIR
  • Five on FHIR
  • Error Code Review
  • M&I Testing for Error Handling
  • Interoperability Hurdles
  • HL7 FAQ
slide-3
SLIDE 3

SISC Update

Mary Woinarowicz

slide-4
SLIDE 4

FHIR Update

Nathan Bunker

slide-5
SLIDE 5

FHIR Update

  • HIMSS20 was cancelled
  • Upcoming meetings:
  • May 16-22, 2020 – WGM & FHIR Connectathon – San Antonio TX
  • May be virtual, status update by April 15
  • Jun 16-18, 2020 – HL7 FHIR DevDays – Cleveland OH
  • Sep 18-25, 2020 – WGM & FHIR Connectathon – Baltimore MD
  • Jan 16-22, 2021 – WGM & FHIR Connectathon – Henderson NV
slide-6
SLIDE 6

Five on FHIR

Danny Wise

slide-7
SLIDE 7

Incoming/Ongoing Data Quality

New Content Area Nathan Bunker

7

slide-8
SLIDE 8

Content Area

Transport Submission / Acknowledgment Query / Response CDS Data Quality - Incoming/ongoing

Testing & Discovery Assessment Validation Testing & Discovery Assessment Validation Testing & Discovery Assessment Validation Testing & Discovery Assessment Testing & Discovery

1 2 3

Assessment

8

slide-9
SLIDE 9

Incoming/Ongoing Data Quality

In Incoming/Ongoing Data we are ensuring that IIS can detect if trading partners (e.g., EHRs, pharmacies, etc.) are sending poor data

9

slide-10
SLIDE 10

The Incoming and Ongoing Data Content Area Isn’t Entirely New…

Submission & ACK Incoming & Ongoing Data Quality

Testing and Discovery

Tests what messages the system said they accept/return, and if they’re conformant Tests what the system actually did with the messages…

10

slide-11
SLIDE 11

Incoming/Ongoing Data Quality Scope

  • In Scope
  • The IIS’s ability to detect data quality issues on a per message basis
  • The IIS’s ability to retain and return vaccination events from

submission to query without changing the meaning

  • Out of Scope
  • Data quality monitoring of multiple messages (e.g., percentage of

records submitted with phone number)

  • Patient or vaccine matching/deduplication algorithms
  • Address hygiene/cleansing

11

slide-12
SLIDE 12

Measuring Data Element Data Quality

Step 1

  • Submit

intentionally poor data

  • E.g., Missing,

Invalid, or Conflicting Data Step 2

  • Submit query

for patient Step 3

  • Analyze ACK

and RSP

12

slide-13
SLIDE 13

Example: Invalid DOB

TEST PASS

slide-14
SLIDE 14

Example: Invalid Phone

TEST FAIL OK

slide-15
SLIDE 15

Key Principle

  • For data quality problems the IIS should either:
  • Alert the sending system about the problem, or
  • Not propagate the data quality problem forward
  • IIS should:
  • Have logic in place to detect data quality problems.
  • After detection decide whether to:
  • Send back AE Error, asking submitter to fix and resent
  • Send back AW Warning, asking submitter to fix
  • Be silent on issue, but fix the data before storing
  • Not forward bad data on to other partners
slide-16
SLIDE 16

Data Element Data Quality Issues

  • Missing data: These tests intentionally omit a data element and

submit the record to the IIS.

  • e.g., The IIS detects the first name is empty
  • Invalid data: These tests intentionally submit an illogical value

and submit the record to the IIS.

  • e.g., The IIS detects the phone number has an invalid value of “no phone”
  • Conflicting data: These tests intentionally submit HL7 messages

per the HL7 Implementation guide, but the data within the message is illogical when compared against other data elements

  • e.g., The IIS detects the vaccination date is before the birth date

16

slide-17
SLIDE 17

Patient Demographic Data Elements

  • Patient name: first
  • Patient name: last
  • Patient date of birth
  • Patient gender
  • Patient ID
  • Patient ID type
  • Race
  • Ethnicity
  • Patient multiple birth indicator
  • Patient birth order
  • Patient address: zip code
  • Patient address: state
  • Patient address: country
  • Patient telephone number
  • Patient telephone number type
  • Patient status indicator – provider

level

  • Responsible person name: first
  • Responsible person name: last
  • Responsible person relationship

to patient

17

slide-18
SLIDE 18

Vaccination Event Data Elements

  • Vaccination administration date
  • Vaccine product
  • Vaccine manufacturer
  • Vaccination event record type
  • Vaccine expiration date
  • Vaccine funding source
  • Dose level eligibility
  • Vaccine event ID
  • Contraindications/precautions
  • Contraindication/precaution
  • bservation date
  • Exemptions/refusals
  • Exemption/refusal date

18

slide-19
SLIDE 19

Interoperability Hurdles

Tracy Little

slide-20
SLIDE 20

AIRA Onboarding Recommendations

https://repository.immregistries.org/resource/onboarding-consensus-based-recommendations/

slide-21
SLIDE 21

Practice question

  • Go to www.menti.com and use code 94 43 19
  • What is your favorite fruit? Share a challenge, solution, or

story.

slide-22
SLIDE 22

Step 1: Discovery & Planning

  • Registration
  • IIS Site Enrollment
  • Forms Completion
  • Other Pre-Prep Activities
  • Checklists
  • Self-service testing
  • Code comparisons
slide-23
SLIDE 23

Step 2: Development and Testing

  • Connectivity and transport
  • Testing environments/platforms
  • Use of test data or production data
  • Volume of records needed for testing/validation
  • Technical vs. programmatic testing
  • Importance of ACKs
  • Self-service opportunities
slide-24
SLIDE 24

Step 3: Production Approval

  • Production approval
  • Pre-production forms completion
  • Training (optional)
  • Move provider credentials to Prod
slide-25
SLIDE 25

Step 4: Ongoing Monitoring

  • Short-term production monitoring
  • Long-term production monitoring
  • Re-onboarding triggers
slide-26
SLIDE 26

Special: Query/Response

  • Differences in processes and procedures compared to

standard interfaces (VXU only)

  • Discovery and Planning
  • Development and Testing
  • Production Approval and Monitoring
  • Additional steps
slide-27
SLIDE 27

HL7 FAQ

Tracy Little

slide-28
SLIDE 28

Now Available on the AIRA Repository

slide-29
SLIDE 29

Next Meeting

April 9, 2020 2:00 pm ET / 11:00 am PT

slide-30
SLIDE 30

More Information

  • Web Links
  • Subscribe to immunization group

http://www.hl7.org/participate/UserGroups.cfm?UserGroup=Immunization

  • Public User Group Wiki

http://www.hl7.org/special/committees/iug/index.cfm

  • Private User Group Wiki

http://iugwiki.hl7.org/

  • HL7 Press Release

http://www.hl7.org/documentcenter/public_temp_F760602A-1C23-BA17- 0C0D326E635471F9/pressreleases/HL7_PRESS_20140402.pdf

  • AIRA Press Release

http://www.immregistries.org/events/2014/04/10/hl7-immunization-user-group

slide-31
SLIDE 31

Contact Information

If you have any questions or comments:

  • Kim Salisbury-Keith Kim.SalisburyKeith@health.ri.gov
  • Nathan Bunker nbunker@immregistries.org
  • Kevin Snow ksnow@envisiontechnology.com
  • Danny Wise Danny.Wise@allscripts.com

Thank you!